DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis Dtsch Med Wochenschr 2009; 134(37): 1812-1816DOI: 10.1055/s-0029-1237516 Aktuelle Diagnostik & Therapie | Review articleGastroenterologie© Georg Thieme Verlag KG Stuttgart · New YorkExtraösophageale Manifestationen der Refluxkrankheit: eine kritische AnalyseExtraesophageal manifestations of gastroesophageal reflux disease: a critical analysisJ. Labenz1 1Medizinische Klinik, Evangelisches Jung-Stilling-Krankenhaus Siegen Artikel empfehlen Abstract Artikel einzeln kaufen(opens in new window) Schlüsselwörter gastroösophageale Refluxkrankheit - GERD - Protonenpumpenhemmer Keywords gastroesophageal reflux disease - GERD - proton pump inhibitor Volltext Referenzen Literatur 1 Chang A B, Lasserson T J, Kiljander T O. et al . Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. Brit Med J. 2006; 332 11-17 2 Coughlan J L, Gibson P G, Henry R L. Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review. Thorax. 2001; 56 198-204 3 Galmiche J P, Zerbib F, Bruley des Varannes S. Review article: respiratory manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008; 27 449-464 4 Garcia-Rodriguez L A, Ruigómez A, Mantin-Merino E, Johansson S, Wallander M -A. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest. 2008; 134 1223-1230 5 Havemann B D, Henderson C, El-Serag H. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007; 56 1654-1664 6 Johnson D A, Orr W C, Crawley J A. et al . Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol. 2005; 100 1914-1922 7 Kiljander T O, Harding S M, Field S K. et al . Effects of esomeprazole 40 mg twice daily on asthma. A randomized placebo-controlled study. Am J Respir Crit Care Med. 2006; 173 1091-1097 8 Koop H. Gastroösophageale Refluxkrankheit – Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol. 2005; 143 163-194 9 Moayyedi P, Axon A TR. Review article: gastro-oesophageal reflux disease – the extent of the problem. Aliment Pharmacol Ther. 2005; 22 (Suppl 1) 11-19 10 Morice A H. Epidemiology of cough. Pulm Pharmacol Ther. 2002; 15 253-259 11 Pace F, Palotta S, Tonini M, Vakil N, Bianchi Porro G. Systematic review: gastro-oesophageal reflux disease and dental lesions. Aliment Pharmacol Ther. 2008; 27 1179-1186 12 Qadeer M A, Phillips C O, Rocio Lopez A. et al . Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006; 101 1-9 13 Richter J E. Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005; 22 (Suppl. 1) 70-80 14 Shaheen N J, Bright S D, Madanick R D. et al . What is the efficacy of high-dose acid suppression in chronic cough? A randomized, souble-blind, placebo-controlled trial. Gastroenterology. 2009; 136 (Suppl 1) 491 15 The A merican Lung Assoication Asthma Clinica Research Centers. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009; 360 1487-1499 16 Vaezi M F. Sore throat and a red hypopharynx: is it reflux?. Clin Gastroenterol Hepatol. 2007; 5 1379-1382 17 Vakil N, van Zanten S, Kahrilas P. et al . The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101 1900-1920 18 Wilder-Smith P E, Wilder-Smith C H, Kawakami-Wong H, Voronets J, Osann K, Lussi A. Quantification of dental erosions in GERD using optical coherence tomography (OTC): an interventional placebo-controlled study. Gastroenterology. 2009; 136 (Suppl 1) W1825 19 Wilder-Smith C H, Wilder-Smith P E, Lussi A. Quantitative and endoscopic characterization of silent gastroesophageal disease (GERD) in patients with advanced erosions. Gastroenterology. 2009; 136 (Suppl 1) W1830 Prof. Dr. med. Joachim Labenz Medizinische Fakultät der Universität Duisburg-Essen, Medizinische Klinik Ev. Jung-Stilling-Krankenhaus Wichernstr. 40 57074 Siegen Telefon: 0271/333-4569 Fax: 0271/333-4242 eMail: J.Labenz@t-online.de